Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
Launched by LUND UNIVERSITY · Oct 25, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new online therapy program designed to help children and teenagers who struggle with anxiety disorders, such as social anxiety, separation anxiety, and panic disorder. The researchers want to see if this internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce anxiety symptoms over a 12-week period. They will check how well the program works by using questionnaires to measure changes in anxiety levels and will also gather feedback from participants, their caregivers, and therapists to improve the program for future use.
To participate in this study, children and teenagers must be between 8 and 17 years old and have a confirmed anxiety disorder. They should also have access to a smartphone, tablet, or computer with the internet and be able to read and write in Swedish. Throughout the study, participants will complete questionnaires at different times, and some may even take part in group discussions to share their experiences with the program. It's important to note that this trial is not yet recruiting participants, but it aims to provide valuable insights into how online therapy can support young people facing anxiety challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1) 8 to \<18 years of age.
- • Confirmed by the child/caregiver and subsequently by the medical record system. 2) A principal DSM-5-TR anxiety disorder of specific phobia, separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, panic disorder or agoraphobia.
- • Confirmed by the Diagnostic Interview for Anxiety, Mood, and OCD and related Neuropsychiatric Disorders - Child and Adolescent Version (DIAMOND-KID).
- • 3) Child and caregiver able to read, write and communicate in Swedish.
- • Confirmed by the child/caregiver. 4) An available caregiver who can support the child in treatment.
- • Confirmed by the caregiver. 5) Access to a smartphone, tablet, or laptop/desktop device, and the internet.
- • Confirmed by the child/caregiver.
- Exclusion Criteria:
- • 1) Principal DSM-5-TR anxiety disorder of specific phobia concerning the domain of blood-injection-injury (due to the ICBT program not including relevant information on applied-tension techniques to avoid fainting during exposure exercises).
- • Confirmed by a blood-injection-injury phobia being classified as the principal anxiety disorder as assessed by the DIAMOND-KID.
- • 2) Established or suspected intellectual disability.
- • Confirmed by the caregiver (through previous diagnosis) and/or by attending a special needs school for learning difficulties.
- • 3) Another mental disorder in more immediate need of management than an anxiety disorder (e.g., schizophrenia spectrum and other psychotic disorders, bipolar disorder, anorexia nervosa, substance use disorders).
- • According to the DIAMOND-KID and/or other available sources. 4) Social/familial/educational difficulties in more immediate need of management than an anxiety disorder.
- • Confirmed by the assessor through information from the child/caregiver and/or other available sources.
- • 5) Immediate risk to self or others that require urgent attention, such as acute suicidality.
- • Confirmed by the assessor through information from the child/caregiver and other available sources.
- • 6) Previous CBT for an anxiety disorder, defined as five or more sessions with a certified CBT therapist within the 12 months prior to assessment.
- • Confirmed by the child/caregiver or the medical record system. 7) Ongoing psychological treatment for an anxiety disorder.
- • Confirmed by the child/caregiver or the medical record system. 8) Initiation or adjustment of any psychotropic medication for anxiety (i.e., selective serotonin reuptake inhibitors, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitor or antipsychotics) within 8 weeks prior to assessment.
- • Confirmed by the child/caregiver or the medical record system. 9) Participation in user involvement sessions in the present study.
- • Confirmed by the researcher.
About Lund University
Lund University, a prestigious research institution in Sweden, is renowned for its commitment to advancing scientific knowledge and innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at addressing critical health challenges. Leveraging its state-of-the-art facilities and a diverse network of expert researchers, Lund University strives to translate research findings into effective therapeutic solutions, ultimately improving patient outcomes and enhancing public health. Through its dedication to ethical research practices and patient safety, Lund University plays a pivotal role in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kalmar, Region Kalmar Län, Sweden
Kalmar, , Sweden
Patients applied
Trial Officials
Per Andrén, PhD
Principal Investigator
Department of Clinical Sciences, Lund, Lund University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported